Investment Bankers are Circling Europe’s Growing Cannabis Market

Author: Pharmadrug |

Pharmadrug Takeaways:

Pharmadrug believes that this is yet another positive data point that cannabis investors are increasingly looking towards Europe for new opportunities.

As Bloomberg points out, there are still only a handful of ways Europeans can access marijuana stocks and cannabis investments. With one of 10 German Class I licenses to distribute medical cannabis throughout the E.U., Pharmadrug is strategically positioned in Europe to take advantage of a burgeoning cannabis market.

As Pharmadrug continues to build out its cannabis presence in Germany and the rest of Europe, we offer a compelling opportunity to cannabis investors looking to participate in the region.

For additional details about Pharmadrug and our medical cannabis operations, please get in touch.